Indeed, this interaction was described in the study by Wu et al.57 Taken together, the transcriptomic profiles and drug screening results suggest the involvement of EGF/FGF pathways in hepatoblastoma tumorigenesis. The gene discussed is EGF; the disease is hepatoblastoma.